| Name: | Description: | Size: | Format: | |
|---|---|---|---|---|
| 2.65 MB | Adobe PDF |
Advisor(s)
Abstract(s)
In 2019, an outbreak of an unknown coronavirus – SARS-CoV-2 – responsible for COVID-19 disease, was first reported in China, and evolved into a pandemic of huge dimensions and raised serious concerns for global health. The number of critical cases continues to increase dramatically, while vaccines and specific treatments are not yet available. There are several strategies currently being studied for the treatment of adverse symptoms of COVID-19, that encompass Acute Lung Injury (ALI)/Acute Respiratory Distress Syndrome (ARDS), extensive pulmonary inflammation, cytokine storm, and pulmonary edema, due to virus-induced pneumonia.
Description
Keywords
Cell-based therapies Secretome Mesenchymal stem cells Coronavirus SARS-CoV-2
Pedagogical Context
Citation
Coelho, A., Alvites, R. D., Branquinho, M. V., Guerreiro, S. G., & Maurício, A. C. (2020). Mesenchymal Stem Cells (MSCs) as a Potential Therapeutic Strategy in COVID-19 Patients: Literature Research. Frontiers in Cell and Developmental Biology, 8, 602647. https://doi.org/10.3389/fcell.2020.602647
Publisher
Frontiers in Cell and Developmental Biology